Curosurf 80 mg/mL
poractant alfa · SUSPENSION · Chiesi USA, Inc.
Curosurf (poractant alfa) is a surfactant medication delivered directly into the lungs through a breathing tube to treat respiratory distress syndrome in newborns. This condition occurs when premature infants lack sufficient natural lung surfactant needed for normal breathing.
Key Facts
- Brand Name
- Curosurf
- Generic Name
- poractant alfa
- NDC Code (Product)
10122-510- Manufacturer
- Chiesi USA, Inc.
- Strength
- 80 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ENDOTRACHEAL
- Marketing Status
- Application #
- BLA020744
- Drug Class
- Surfactant [EPC]
- Marketing Start
- 11/18/1999
Recall History
No Recall HistoryFrequently Asked Questions
What is Curosurf used for?
Curosurf (poractant alfa) is a surfactant medication delivered directly into the lungs through a breathing tube to treat respiratory distress syndrome in newborns. This condition occurs when premature infants lack sufficient natural lung surfactant needed for normal breathing.
Is Curosurf a controlled substance?
Curosurf is not classified as a controlled substance by the DEA.
What is the generic name for Curosurf?
The generic name for Curosurf is poractant alfa. There are no other listed brand versions of poractant alfa.
What is the NDC code for Curosurf 80 mg/mL?
The NDC (National Drug Code) for Curosurf 80 mg/mL is 10122-510, listed by Chiesi USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)